Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Onco LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.50p +1.08% 47.00p 46.00p 48.00p 47.00p 46.50p 46.50p 23,130 09:29:30
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 0.0 -13.2 -17.0 - 73.15

Advanced Onco Share Discussion Threads

Showing 5201 to 5225 of 5225 messages
Chat Pages: 209  208  207  206  205  204  203  202  201  200  199  198  Older
DateSubjectAuthorDiscuss
19/6/2018
18:37
Well - I emailed Israel Proton Therapy (.com) and had a very intriguing reply. I won’t share on here but they are indeed actively looking at options. I’ll be topping up at this price. GLA. Do your own research. People will answer genuine questions.
paul_98
19/6/2018
16:42
Paul you know I think you maybe right, particularly when you see the costs as they are talking about fully establishing a proton therapy center for $60m and $6m a year running costs. The only system I know that could come anywhere near these costs is LIGHT, also interesting like AVO have promoted in Harley Street an emphasis on treating children.. .good find, lets hope we have some more news with the new distribution partner in China and some confirmed orders soon! Only around 3 months to go and AVO will have a fully functional LIGHT system treating superficial tumors then the fun will be begin followed by regulatory approval.
makeamillion1
19/6/2018
11:46
I think AVO may be being considered by Israel’s proton therapy development. Do your own research
paul_98
15/6/2018
18:30
It is quite common for an share price to decline in the absence of news. Nothing to worry about if the company is sound, well run and making good profits but could be a bit troubling if it is not. With the right company, some might see it as a buying opportunity.
daijavu
15/6/2018
16:25
Can anyone explain the dip? Without absolutely slating the company (!).
paul_98
12/6/2018
19:09
Fingers crossed. Must say I have a good feeling about this. GLA.
paul_98
12/6/2018
13:19
looks VERY strong! charts indicating major surge towards three digits in not too distant future.
baner
11/6/2018
11:30
Very decent buying volumes. I wonder if news is afoot?!
paul_98
07/6/2018
08:27
A quiet period while we await more excellent news I feel.
paul_98
04/6/2018
08:25
Big job. hTTps://www.glassdoor.co.uk/Job/switzerland-advanced-oncotherapy-jobs-SRCH_IL.0,11_IN226_KE12,32.htm?jl=2789157559
paul_98
04/6/2018
08:12
Yes, I see quite a few of the negative type posters have gone very quiet though!
paul_98
31/5/2018
17:26
Paul Indeed - it is sad these morons keep on even when they are proven absolutely and totally wrong, however there is also a comical aspect in this. And hopefully they supply the market with further short sold stock, allowing sound investors to extend their profits in this. Personally i am in massivet at 10p and 25p and looking forward to exit north of 100p - no doubt able to buy myself a posh house in the south of france for my profit. A special thanks to ”wiseacre̶1; et al!
baner
31/5/2018
16:00
More positive news brings out the sour posters as usual! Lol it’s funny. Happy days!
paul_98
31/5/2018
15:56
dream on baby
wiseacre
31/5/2018
15:20
wiseacre - sounds like you have been smoking what TW claims everyone else is. Please sell all you have it is because of comments like yours and TW I am making substantial profits....thank you For all those who have also followed some of the best medical professionals in the world working for this company, followed some seriously successful multi millionaires who are heavily invested, IMO I have no doubt about the future success of the company. All I do know IMHO by the time we are treating superficial tumors by end of Q3 2018 I would expect the share price to have accelerated substantially. The next land mark after that will be getting regulatory approval and working with the UK Government's Science and Technology Facilities Council ("STFC") where the company has announced they are to establish a UK testing and assembly site for its next generation proton accelerator. GLA all good news!
makeamillion1
31/5/2018
15:07
It's great that you took the trouble to post that here Looking back over the past year or so though, there is a familiar pattern, whereby every single one of these 'speculations' has come to nothing.
marvin66
31/5/2018
14:45
AIM-listed Advanced Oncotherapy (AVO) announced this morning that Bracknor, the death spiral funder, still had convertible loan notes to swap for shares. This, despite the RNS of 19 July 2017 telling us that the Company does not intend to use the Bracknor facility in the future. As part of these arrangements the Company will issue 7 million warrants to Bracknor. These warrants are exercisable at 25p and may be exercised at any time over the next five years. Anyone would have thought that was the end of the matter. Apparently not. The 19 July info was not a lie, but it does look to have been materially misleading in that it was incomplete. So I have a few more questions: what about all the warrants? There are 7 million (exercisable at 25p) above. And then there are all the warrants associated with the death spiral conversions on top. Would Advanced Oncotherapy like to tell us how many are outstanding, and what the exercise prices are? As far as I can see, it looks as though Bracknor has another wall of confetti to land on the market. With the shares still up at 53.5p (mid), you have to see a return to 25p on the cards. The warrants associated with conversion of death spiral notes were originally announced as being: Upon issuance of a tranche, Bracknor shall receive warrants to purchase shares with an aggregate value equivalent to 20% of the nominal value of each tranche. These warrants will be exercisable for up to four years from issue; o For the first tranche, the exercise price will be 130% of the lowest of either (a) the lowest daily VWAP during the ten trading days preceding the signing of the Agreement or (b) the lowest daily VWAP of the 10 trading days preceding the request to issue the first tranche; o The exercise price of the subsequent warrants (i.e. bar the first tranche), will be 130% of the lowest daily VWAP during the five trading days immediately preceding the request to issue a new tranche; That sounds like one heck of a lot of warrants! Finally, we are told that the outstanding convertible loans have been settled at 46p and passed on to an outfit called M3T PTE Ltd. We are told that Bracknor no longer holds convertible loans in Advanced – well, no, but what about all those warrants? Also, there is a wording issue which suggests this might not be the last pile of confetti. We are told: In addition, the Company announces that further to previous announcements regarding the Bracknor funding facility, all outstanding Convertible Loan Notes ("CLN") owned by Bracknor are being converted into new ordinary shares of 25p issued ("Ordinary Shares") at a price of 46p. As part of this transaction, 5,127,560 Ordinary Shares are being issued as a result of the conversion and the satisfaction of the payment of conversion fee and commitment fees (the "Conversion"). (my emphasis) So what else is Bracknor getting? Are there more conversion shares beyond the 5,127,560 above that we’ve not yet been told about? We are told Bracknor holds no more CLNs, but what about shares? Yet again, I don’t think we’ve yet been told the whole truth here. The good news is that the Chinese money appears to be in the bank. The bad news is that I suspect Bracknor still has quite a hand left to play – I doubt the wording anomaly above was an accident. Meanwhile, I reckon Advanced still needs to raise yet more money. Would Advanced care to clarify, ahead of the next placing, what warrants are outstanding to Bracknor and on what terms, and how many shares has Bracknor got? Until it does, the shares remain a stonking sell – with 25p the obvious short-term price target. Longer term, of course, for all the reasons HERE, 0p looks the likely target in the end.
wiseacre
31/5/2018
08:25
Well said Baner. I think ‘they’ will be very sheepish from now on. All well on track and the huge potential will now be reached I’m sure.
paul_98
31/5/2018
08:18
Excellent news re the ”missing millions” today. The chinese have now invested £30m in AVO - before the proton system is even completed. This confirm they have made a very indepth due diligence and clearly see a huge potential for AVO systems in the Far East. So funding is secured, the tech reports are indeed bullish - time for the bears to go for a long sleep...........congratulations to those who have supported the company in its development of this life-saving technique, and shame on those ”contributors” to this site who have lent them selves to attempts to talk this important company down.
baner
30/5/2018
08:44
You should read the technology description on AVO's website. Their proton beam system is modular which means that additional accelerator units increase the power of the beam. Testing (and certification) is therefore an iterative process which explains why they are proceeding in stages (the certification and licensing process cannot be underestimated - you are dealing with a powerful radiation generator here, so each time you increase its power the certification issues will be ever more onerous).
freddythefish
30/5/2018
06:56
With much of the technological development now de-risked, the Company is on target to have a system capable of treating superficial tumours by the end of Q3 2018. what does this sentence actually mean? presumably not that they will have a machine ready or they would have said so.
acliff
30/5/2018
06:56
With much of the technological development now de-risked, the Company is on target to have a system capable of treating superficial tumours by the end of Q3 2018. what does this sentence actually mean? presumably not that they will have a machine ready or they would have said so.
acliff
30/5/2018
01:03
Avos is able to do the same, the difference between the two is that Avos is cheaper in cost to make and smaller in size to store.
adealsiddiq110
29/5/2018
23:30
I expect the London site refers to the second big NHS one (after Manchester) that will be treating patients free from 2020, and proper high energy units which can treat deep tumours. (Unlike AVO's Harley St site)
scantrader
29/5/2018
18:44
I hope this comes good to actually help people like that child. :-(
paul_98
Chat Pages: 209  208  207  206  205  204  203  202  201  200  199  198  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180622 09:39:11